Open AccessMetabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Author(s) -
Mouna Mnif,
Mahdi Kamoun,
F. Mnif,
Nadia Charfi,
B. Ben Naceur,
N. Kallel,
N. Rekik,
Z. Mnif,
M.H. Sfar,
Mohamed Tahar Sfar,
M. Hachicha,
M. Abid
Publication year - 2012
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.102995
Subject(s) - medicine , congenital adrenal hyperplasia , 21 hydroxylase , pediatrics , endocrinology
In congenital adrenal hyperplasia (CAH), long-term glucocorticoid treatment coupled with increased androgens may lead to undesirable metabolic effects. The aim of our report was to determine the prevalence of metabolic abnormalities and cardiovascular risk factors in a population of adult patients with CAH due to 21 hydroxylase deficiency.